203 related articles for article (PubMed ID: 24811957)
1. Breast cancer redox heterogeneity detectable with chemical exchange saturation transfer (CEST) MRI.
Cai K; Xu HN; Singh A; Moon L; Haris M; Reddy R; Li LZ
Mol Imaging Biol; 2014 Oct; 16(5):670-9. PubMed ID: 24811957
[TBL] [Abstract][Full Text] [Related]
2. Magnetization Transfer MRI Contrast May Correlate with Tissue Redox State in Prostate Cancer.
Tain R; Xu HN; Zhou XJ; Li LZ; Cai K
Adv Exp Med Biol; 2016; 923():401-406. PubMed ID: 27526169
[TBL] [Abstract][Full Text] [Related]
3. Characterizing prostate tumor mouse xenografts with CEST and MT-MRI and redox scanning.
Cai K; Xu HN; Singh A; Haris M; Reddy R; Li LZ
Adv Exp Med Biol; 2013; 765():39-45. PubMed ID: 22879012
[TBL] [Abstract][Full Text] [Related]
4. Amide proton transfer imaging of glioblastoma, neuroblastoma, and breast cancer cells on a 11.7 T magnetic resonance imaging system.
Tanoue M; Saito S; Takahashi Y; Araki R; Hashido T; Kioka H; Sakata Y; Yoshioka Y
Magn Reson Imaging; 2019 Oct; 62():181-190. PubMed ID: 31302222
[TBL] [Abstract][Full Text] [Related]
5. Imaging chemical exchange saturation transfer (CEST) effects following tumor-selective acidification using lonidamine.
McVicar N; Li AX; Meakin SO; Bartha R
NMR Biomed; 2015 May; 28(5):566-75. PubMed ID: 25808190
[TBL] [Abstract][Full Text] [Related]
6. A new contrast in MR mammography by means of chemical exchange saturation transfer (CEST) imaging at 3 Tesla: preliminary results.
Schmitt B; Zamecnik P; Zaiss M; Rerich E; Schuster L; Bachert P; Schlemmer HP
Rofo; 2011 Nov; 183(11):1030-6. PubMed ID: 22034086
[TBL] [Abstract][Full Text] [Related]
7. CEST-MRI detects metabolite levels altered by breast cancer cell aggressiveness and chemotherapy response.
Chan KW; Jiang L; Cheng M; Wijnen JP; Liu G; Huang P; van Zijl PC; McMahon MT; Glunde K
NMR Biomed; 2016 Jun; 29(6):806-16. PubMed ID: 27100284
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer imaging with glucosamine CEST (chemical exchange saturation transfer) MRI: first human experience.
Rivlin M; Anaby D; Nissan N; Zaiss M; Deshmane A; Navon G; Sklair-Levy M
Eur Radiol; 2022 Nov; 32(11):7365-7373. PubMed ID: 35420304
[TBL] [Abstract][Full Text] [Related]
9. Quantitative mitochondrial redox imaging of breast cancer metastatic potential.
Xu HN; Nioka S; Glickson JD; Chance B; Li LZ
J Biomed Opt; 2010; 15(3):036010. PubMed ID: 20615012
[TBL] [Abstract][Full Text] [Related]
10. Potential Indexing of the Invasiveness of Breast Cancer Cells by Mitochondrial Redox Ratios.
Sun N; Xu HN; Luo Q; Li LZ
Adv Exp Med Biol; 2016; 923():121-127. PubMed ID: 27526133
[TBL] [Abstract][Full Text] [Related]
11. Multiparametric chemical exchange saturation transfer MRI detects metabolic changes in breast cancer following immunotherapy.
Hoffmann E; Schache D; Höltke C; Soltwisch J; Niland S; Krähling T; Bergander K; Grewer M; Geyer C; Groeneweg L; Eble JA; Vogl T; Roth J; Heindel W; Maus B; Helfen A; Faber C; Wildgruber M; Gerwing M; Hoerr V
J Transl Med; 2023 Aug; 21(1):577. PubMed ID: 37641066
[TBL] [Abstract][Full Text] [Related]
12. CEST MRI of 3-O-methyl-D-glucose on different breast cancer models.
Rivlin M; Navon G
Magn Reson Med; 2018 Feb; 79(2):1061-1069. PubMed ID: 28497566
[TBL] [Abstract][Full Text] [Related]
13. Extracellular pH is a biomarker enabling detection of breast cancer and liver cancer using CEST MRI.
Chen M; Chen C; Shen Z; Zhang X; Chen Y; Lin F; Ma X; Zhuang C; Mao Y; Gan H; Chen P; Zong X; Wu R
Oncotarget; 2017 Jul; 8(28):45759-45767. PubMed ID: 28501855
[TBL] [Abstract][Full Text] [Related]
14. Deep learning-based classification of preclinical breast cancer tumor models using chemical exchange saturation transfer magnetic resonance imaging.
Bie C; Li Y; Zhou Y; Bhujwalla ZM; Song X; Liu G; van Zijl PCM; Yadav NN
NMR Biomed; 2022 Feb; 35(2):e4626. PubMed ID: 34668251
[TBL] [Abstract][Full Text] [Related]
15. Unlabeled aspirin as an activatable theranostic MRI agent for breast cancer.
Pavuluri K; Yang E; Ayyappan V; Sonkar K; Tan Z; Tressler CM; Bo S; Bibic A; Glunde K; McMahon MT
Theranostics; 2022; 12(4):1937-1951. PubMed ID: 35198081
[No Abstract] [Full Text] [Related]
16. Potential Biomarker for Triple-Negative Breast Cancer Invasiveness by Optical Redox Imaging.
Feng M; Xu HN; Jiang J; Li LZ
Adv Exp Med Biol; 2021; 1269():247-251. PubMed ID: 33966225
[TBL] [Abstract][Full Text] [Related]
17. Characterizing breast cancer mouse xenografts with T₁ρ -MRI: a preliminary study.
Li LZ; Xu HN; Reddy R
Adv Exp Med Biol; 2011; 701():137-42. PubMed ID: 21445780
[TBL] [Abstract][Full Text] [Related]
18. Relaxation-compensated CEST-MRI at 7 T for mapping of creatine content and pH--preliminary application in human muscle tissue in vivo.
Rerich E; Zaiss M; Korzowski A; Ladd ME; Bachert P
NMR Biomed; 2015 Nov; 28(11):1402-12. PubMed ID: 26374674
[TBL] [Abstract][Full Text] [Related]
19. Relaxation-compensated CEST (chemical exchange saturation transfer) imaging in breast cancer diagnostics at 7T.
Loi L; Zimmermann F; Goerke S; Korzowski A; Meissner JE; Deike-Hofmann K; Stieber A; Bachert P; Ladd ME; Schlemmer HP; Bickelhaupt S; Schott S; Paech D
Eur J Radiol; 2020 Aug; 129():109068. PubMed ID: 32574936
[TBL] [Abstract][Full Text] [Related]
20. Multislice CEST MRI improves the spatial assessment of tumor pH.
Randtke EA; Granados JC; Howison CM; Pagel MD; Cárdenas-Rodríguez J
Magn Reson Med; 2017 Jul; 78(1):97-106. PubMed ID: 27465207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
